Bend Research, part of Capsugel’s Dosage Form Solutions (DFS) business unit, is investing more than $20 million to expand commercial manufacturing for spray-dried dispersions at its facilities in Bend, OR. The company is adding two new high-capacity PSD spray dryer process trains capable of handling high-risk/high-potency compounds. The commercial facility expansion, along with the existing GMP development and manufacturing facility, will be completed and validated by mid-2015.   In addition to ...